Cytek Biosciences, Inc.
CTKB- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001831915
No open-market purchases or sales by Cytek Biosciences, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $361.0M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2023
Institutional positions in Cytek Biosciences, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- +6 vs. Q2 2023
- Shares held
- 77.4M
- +371.1K (+0.5%) vs. Q2 2023
- Total value
- $427.7M
- −$230.2M (−35.0%) vs. Q2 2023
- New holders
- 18
- 54 more added
- Sold out
- 12
- 23 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTKB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 154 | $361.0M |
| Q1 2026 | 165 | $371.8M |
| Q4 2025 | 155 | $414.3M |
| Q3 2025 | 153 | $277.4M |
| Q2 2025 | 158 | $270.0M |
| Q1 2025 | 161 | $310.8M |
| Q4 2024 | 153 | $501.4M |
| Q3 2024 | 136 | $415.3M |
| Q2 2024 | 129 | $425.1M |
| Q1 2024 | 125 | $540.9M |
| Q4 2023 | 105 | $719.9M |
| Q3 2023 | 107 | $427.7M |
| Q2 2023 | 101 | $657.9M |
| Q1 2023 | 102 | $629.6M |
| Q4 2022 | 103 | $654.1M |
| Q3 2022 | 88 | $898.5M |
| Q2 2022 | 85 | $567.8M |
| Q1 2022 | 74 | $514.5M |
| Q4 2021 | 52 | $571.9M |
| Q3 2021 | 54 | $733.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Cytek Biosciences, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 2,354,452 | $13.0M | 0.00% | +292,150+14.2% | Added |
| State Street Corp | 3,777,543 | $20.9M | 0.00% | +370,108+10.9% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 6,657,030 | $36.7M | 0.82% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 6,809,404 | $37.6M | 0.74% | −5,488,317−44.6% | Reduced |
| Vanguard Group Inc | 11,079,421 | $61.2M | 0.00% | +461,142+4.3% | Added |
| Brown Capital Management LLC | 13,560,480 | $74.9M | 1.15% | +2,828,797+26.4% | Added |
| BlackRock Inc. | 16,770,673 | $92.6M | 0.00% | +1,643,168+10.9% | Added |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,253,715−100.0% | Sold out |
| Miura Global Management, LLC | 0 | $0 | 0.00% | −380,591−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −115,545−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −67,320−100.0% | Sold out |
| Parkwood LLC | 0 | $0 | 0.00% | −48,244−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −18,300−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −17,028−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −69−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |